HCPCS 2009 > Q Codes >

 2009 HCPCS Q0180

Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen

• Added on Wednesday, April 01, 1998
• BETOS Classification: Chemotherapy
• Medicare coverage status: Special coverage instructions apply

  Q0179    Q0181